Agoraphobia, Depression, Generalized Anxiety Disorder, Panic Disorder, Social Phobia
Conditions
Brief summary
Background: There is need for more effectiveness studies concerning treatment of emotional symptom problems indicating anxiety and depression in adolescents. SMART is the only treatment manual for combined emotional disorders developed in Norwegian. Purpose: To find the best individualized treatment for adolescents with emotional difficulties by: Finding criteria for the selection of appropriate patients for treatment with cognitive-behavior therapy program SMART in an outpatient population (14-18 years). Finding predictors of completion of treatment program SMART. Examining the effects of treatment with the SMART program at 6 months follow-up. Design: A randomized controlled study in six outpatient clinics in the north of Norway. N= 160 referred adolescents (14-18 years) with score above 6 on the Emotional Problems scale of the Strength and Difficulties Questionnaire (SDQ). Two thirds are treated according to the SMART-manual immediately, while the waiting list control group is treated with SMART after six weeks. Hypothesis: The SMART treatment is an effective treatment for emotional symptom problems. Publication: The results sought published internationally and nationally and will be communicated to clinicians.
Interventions
BEHAVIORALSMART manual cognitive behavioral therapy
Sponsors
The Royal Norwegian Ministry of Health
Regionsenter for barn og unges psykiske helse
University of Tromso
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
14 Years to 18 Years
Healthy volunteers
No
Inclusion criteria
Age 14 to 18 years Referred to Community Mental Health Clinic for Children and Adolescents * Score above 6 on Emotional symptoms scale on the SDQ Fluent Norwegian language
Exclusion criteria
* Indicators for Pervasive Developmental Disorder (PDD) Acute suicidal symptoms Psycho-active drug treatment start coinciding with start of intervention Symptoms indicating psychotic disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Status of primary emotional disorder based on theDevelopment and Well-Being Assessment (DAWBA) interview schedule with parents and youths | At recruitment, before treatment start and at 6 months follow up | Diagnostic interview |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| SDQ Strengths and Difficulties Questionnaire | At recruitment, before treatment start and at 6 months follow up | Measure of general emotional and behavioral symptoms and strengths |
| Anxiety symptom score on the Multi-Dimensional Anxiety Scale for Children (MASC) | At recruitment, before treatment start and at 6 months follow up | Measure of anxiety symptoms |
| Depression symptom status as measured by the self-rating instrument Beck Depression Inventory (BDI-II) | At recruitment, before treatment start and at 6 months follow up | Measure of depressive symptoms |
| Life functioning as measured by the rating scale C-GAS rated by clinicians | At recruitment, before treatment start and at 6 months follow up | Measure of functioning |
| General outcome measured by Clinical Outcomes in Routine Evaluations Outcome Measure (CORE-OM) | At recruitment, before treatment start and at 6 months follow up. The short version (CORE 10) mid-therapy: 3 weeks after starting treatment | Measure of symptoms, risk, functioning and total burden of disorder |
Countries
Norway
Outcome results
None listed